National Institutes of Health (NIH) Awards Another Major Grant to ImmunogenX to Conduct a Clinical Trial for Latiglutenase (August 2019)

ImmunogenX Initiates Phase 2 Trial for its Lead Therapeutic and Diagnostic Candidates Latiglutenase and CypCel (March 2019)

ImmunogenX (50 Best Companies to Watch 2018: May 2018)

Dr. Jennifer Sealey Voyksner and Dr. Jack Syage speak at National Conference (Celiac Disease Foundation: May 5th, 2018)

The Dilemma of the Gluten-Free Diet (Wall Street Journal: April 16th, 2018)

When Going Gluten-Free Is Not Enough: New Tests Detect Hidden Exposure (NPR: April 3rd, 2018)

Gluten-Free Diet May Still Allow Harmful Levels of Exposure (Reuters: March 21st, 2018)